BGM (BGM Group) EPS (Basic) : $-0.20 (TTM As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is BGM Group EPS (Basic)?

BGM Group's basic earnings per share (Basic EPS) for the six months ended in Sep. 2024 was $-0.25. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Sep. 2024 was $-0.20.

BGM Group's EPS (Diluted) for the six months ended in Sep. 2024 was $-0.25. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was $-0.20.

BGM Group's EPS without NRI for the six months ended in Sep. 2024 was $-0.06. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Sep. 2024 was -0.14.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 8 years, BGM Group's highest 3-Year average EPS without NRI Growth Rate was 52.50% per year. The lowest was -30.90% per year. And the median was -19.40% per year.

BGM Group EPS (Basic) Historical Data

The historical data trend for BGM Group's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BGM Group EPS (Basic) Chart

BGM Group Annual Data

Trend

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Sep24

EPS (Basic)

Get a 7-Day Free Trial

0.72

0.45

0.15

-1.08

-0.20

BGM Group Semi-Annual Data
	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24
EPS (Basic)	Get a 7-Day Free Trial										0.14	0.05	-1.13	0.05	-0.25

BGM Group EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

BGM Group's Basic EPS for the fiscal year that ended in Sep. 2024 is calculated as

Basic EPS (A: Sep. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-1.443	-	0)	/	7.226
	=	-0.20

BGM Group's Basic EPS for the quarter that ended in Sep. 2024 is calculated as

Basic EPS (Q: Sep. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-1.857	-	0)	/	7.303
	=	-0.25

EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-0.20

BGM Group (NAS:BGM) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

BGM Group EPS (Basic) Related Terms

Thank you for viewing the detailed overview of BGM Group's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

BGM Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BGM Group Ltd (NAS:BGM) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 152 Hongliang East 1st Street No. 1703, Tianfu New District, Chengdu, CHN, 610200

Website

https://www.bgmgroupltd.com

BGM Group Ltd is a biopharmaceuticals, bio-extraction, and medical health business. Its product range includes oxytetracycline APIs, licorice preparations, and crude heparin sodium. Maximum revenue is from Oxytetracycline & Licorice and TCMD, followed by Heparin products and Sausage casing.